← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 31, 2014Last known activity
Jan 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT06029530CollaboratorPhase 1Jan 1, 2024
- NCT05482997Overall official - principal investigatorN/AJan 31, 2023
- NCT05482997Reponsible party - principal investigatorN/AJan 31, 2023
- NCT05482997Lead sponsorN/AJan 31, 2023
- NCT04676126Lead sponsorPhase 4Jan 31, 2021
- NCT04234932Reponsible party - principal investigatorEarly Phase 1Jan 31, 2020
- NCT04234932Lead sponsorEarly Phase 1Jan 31, 2020
- NCT03326934Overall official - principal investigatorN/AJun 25, 2017
- NCT03326934Lead sponsorN/AJun 25, 2017
- NCT02956083Lead sponsorN/AJul 31, 2014
- NCT02956083Overall official - principal investigatorN/AJul 31, 2014
Details
- Last known activity
- Jan 1, 2024